BioRestorative Therapies (BRTX) Set to Announce Quarterly Earnings on Wednesday

BioRestorative Therapies (NASDAQ:BRTXGet Free Report) is scheduled to announce its earnings results on Wednesday, March 27th.

BioRestorative Therapies Stock Up 0.7 %

NASDAQ:BRTX opened at $1.40 on Tuesday. BioRestorative Therapies has a 52 week low of $1.20 and a 52 week high of $7.13. The company has a 50-day moving average of $1.52 and a 200-day moving average of $1.72.

Insiders Place Their Bets

In other BioRestorative Therapies news, major shareholder Dale Broadrick purchased 86,041 shares of the stock in a transaction dated Friday, February 9th. The stock was bought at an average price of $1.32 per share, for a total transaction of $113,574.12. Following the transaction, the insider now directly owns 477,972 shares in the company, valued at $630,923.04. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 21.60% of the company’s stock.

Institutional Trading of BioRestorative Therapies

A hedge fund recently raised its stake in BioRestorative Therapies stock. Vanguard Group Inc. boosted its position in shares of BioRestorative Therapies, Inc. (NASDAQ:BRTXFree Report) by 8.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 137,818 shares of the company’s stock after acquiring an additional 10,862 shares during the quarter. Vanguard Group Inc. owned 2.93% of BioRestorative Therapies worth $247,000 at the end of the most recent reporting period. 69.38% of the stock is currently owned by hedge funds and other institutional investors.

About BioRestorative Therapies

(Get Free Report)

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.

See Also

Earnings History for BioRestorative Therapies (NASDAQ:BRTX)

Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with's FREE daily email newsletter.